Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: Comparison with conventional B-mode ultrasound

Digestive Diseases

Volumn 25, Issue 1, 2007, Pages 86-93

  Yarmenitis, S D ^a   Karantanas, A ^a,b   Bakantaki, A ^a   Papantoniou, Y ^a   Gourtsoyiannis, N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Colorectal cancer imaging; Contrast media; Liver neoplasms ultrasonography; Metastatic disease diagnosis

Indexed keywords

CONTRAST MEDIUM; SONOVUE;

ADULT; AGED; ARTICLE; B SCAN; CALCULATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL IMAGING; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER; LIVER METASTASIS; LIVER PARENCHYMA; LIVER SINUSOID; MALE; PRIORITY JOURNAL; SCORING SYSTEM; ULTRASOUND;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 33947584245     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099175     Document Type: Article

References (14)

1. Cosgrove DO, Bolondi L: Malignant liver disease; in Cosgrove D, Meire H, Dewbury K (eds): Abdominal and General Ultrasound. Edinburgh, Churchill Livingstone, 1993, pp 271-293.
2. Wernecke K, Rummeny E, Bongartz G, et al: Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT and MR imaging. AJR Am J Roentgenol 1991;157:731-739.
3. Bleuzen A, Tranquart F: Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing and SonoVue. Eur Radiol 2004;14(suppl 8):P53-P62.
4. Quaia E, Calliada F, Bertolotto M, et al: Characterization of focal liver lesions by contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-430.
5. Blomley MJ, Albrecht TA, Cosgrove DO, et al: Improved detection of liver metastases with stimulated acoustic emission in late phase of enhancement with the US contrast agent SH U 508: early experience. Radiology 1999;210:409-416.
6. Harvey CJ, Blomley MJ, Eckersley RJ, et al: Hepatic malignancies: improved detection with pulse inversion US in late phase of enhancement with SH U 508 A - early experience. Radiology 2000;216:903-908.
7. Quaia E, Bertolotto M, Forgács B, et al: Detection of liver metastases by pulse inversion harmonic imaging during levovist late phase: comparison to conventional ultrasound and helical CT in 160 patients. Eur Radiol 2003;13:475-483.
8. Albrecht T, Blomley MJK, Burns PN, et al: Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361-370.
9. Oldenburg A, Hohmann J, Foert E, et al: Detection of hepatic metastases with low MI real time contrast-enhanced sonography and SonoVue. Ultraschall Med 2005;26:277-284.
10. Whittingham T: Contrast-specific imaging techniques: technical perspective; in Quaia E (ed): Contrast Media in Ultrasonography: Basic Principles and Clinical Applications. Berlin, Springer, 2005, pp 43-70.
11. Krix M, Plathow C, Essig M, et al: Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound - initial results. Eur Radiol 2005;15:677-684.
12. Quaia E, D'Onofrio M, Palumbo A, et al: Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol DOI 2006;10.1007/s00330-006-0192-7.
13. Hohmann J, Albrecht T, Hoffmann CW, et al: Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 2003;46:147-159.
14. Harvey CJ, Albrecht T: Ultrasound of focal liver lesions. Eur Radiol 2001;11:1578-1593.